ID,MEDICATION,GENE(S),PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST,INTERACTION
N24-008,Rabeprazole,CYP2C19,"Minor â€“ result should be considered as may affect medicationresponse",NA
N24-008,Atorvastatin,"CYP3A4SLCO1B1",Usual prescribing considerations apply,NA
N24-008,Citalopram,CYP2C19,Usual prescribing considerations apply,NA
N24-008,Gliclazide,"CYP2C19CYP2C9",Usual prescribing considerations apply,NA
N24-008,Metoprolol,CYP2D6,Usual prescribing considerations apply,NA
N24-008,candesartan (Candesartan),NA,NO,NA
N24-008, metformin,NA,NO,NA
N24-008, acetylsalicylic acid (Asa),NA,NO,NA
N24-008, insulin (Humalog),NA,NO,NA
N24-008, insulin (NovoRapid),NA,NO,NA
